Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection - The Lancet
COVID-19 BOOSTER VACCINE EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION – in reducing breakthrough, duration of benefit
Booster shots highlighted in new breakthrough case report : Oregon Health News Blog
Booster shots highlighted in new breakthrough case report : Oregon Health News Blog
Breakthrough COVID-19 infections and deaths rose during delta, but far outpaced by the unvaccinated - ABC News
Who Had Covid-19 Vaccine Breakthrough Cases? - The New York Times
Who Had Covid-19 Vaccine Breakthrough Cases? - The New York Times
The epidemiological relevance of the COVID-19-vaccinated population is decreasing after booster vaccination, as shown by incidence rate ratios - The Lancet Regional Health – Europe
Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2 | Nature Medicine
The Scoop on Breakthrough Infections: Are You at Risk?
Vaccines | Free Full-Text | Neutralizing Antibodies as Predictors of Vaccine Breakthrough Infection in Healthcare Workers Vaccinated with or without a Heterologous Booster Dose: A Cohort Study during the Third COVID-19 Wave
Frontiers | Review of Clinical Trials of COVID-19 Vaccination Booster in SARS-CoV-2 Variants Era: To Take It or Not To Take It
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants | Science Immunology
Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK) - The Lancet Regional Health –
Patients with cancer at high risk for death due to breakthrough COVID-19 infections
Breakthrough infections, hospital admissions, and mortality after major COVID-19 vaccination profiles: a prospective cohort study - The Lancet Regional Health - Southeast Asia
Vaccine Breakthrough Infections with SARS-CoV-2 Variants | NEJM
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants | Science Immunology
COVID-19 vaccine breakthrough infections | Science
Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges - ScienceDirect
HKUMed reports that timely booster vaccination reduces Omicron breakthrough infections and COVID-19 severity - All News - Media - HKU
COVID-19 BOOSTER VACCINE EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION – in reducing breakthrough, duration of benefit
breakthrough infections – NIH Director's Blog
Vaccines | Free Full-Text | Time-Varying Effect of Hybrid Immunity on the Risk of Breakthrough Infection after Booster Dose of mRNA COVID-19 Vaccine: The MOSAICO Study
Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study | The BMJ
Vaccines | Free Full-Text | Breakthrough SARS-CoV-2 Infections after Vaccination in North Carolina
